Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Does Venturis really think we're all that stupid? Apparently the answer is yes:
https://www.prnewswire.com/news-releases/venturis-therapeutics-inc-announces-its-applications-for-four-new-patents-related-to-the-use-of-therapeutic-angiogenesis-in-the-treatment-of-illnesses-related-to-the-covid-19-virus-as-well-as-illnesses-related-to-other-viruses-301053489.html?tc=eml_cleartime
This really requires no comment. It's so obvious as to be laughable. I'm laughing at least! File this one under "Re-arranging the deck chairs on the Titanic after it hit the iceberg."
Here's what's really happening: Venturis Therapeutics (formerly Cardiovascular Biotherapeutics or CVBT) is within days of finding out from the judge/arbitrator how large the game-ending judgement will be that it has to pay Dan Montano (it's in the many millions; we will soon find out how many). As a company that has long been insolvent and illiquid, my best guess is that once Dan Montano moves into collection mode, we will quickly see a bankruptcy filing by Venturis Therapeutics.
For more information:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155218989
SCAM ALERT: On the eve of Venturis going out of business after suffering a catastrophic, multi-million dollar judgement at the hands of Dan Montano that it likely can not pay short of liquidation (and the liquidation proceeds won't come close to covering the judgment), it appears someone on this message board is trying to get others to buy shares of Venturis Therapeutics stock at "discounted" prices. Everyone should be mindful that Venturis is a de-listed, insolvent, illiquid, and all-but-bankrupt company that hasn't run a single clinical trial since 2007. If I'm reading these postings correctly, such transactions somehow involve Grant Gordon. Is Grant Gordon directly involved in this shady scheme? I have my own opinion.
BEWARE!
Here's more information:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155218989
I'm curious, is Venturis leadership disclosing the all-but-certainly impending bankruptcy filing to prospective investors?
For more information:
https://investorshub.advfn.com/CardioVascular-BioTherapeutics-(fka-CVBT)-3774/
When will Venturis learn what the judge/arbitrator has awarded in damages to Dan Montano? Those who pooh-pooh this as much ado about nothing can say whatever they want, but we will soon have a number, and in my opinion it is game-ending for Venturis Therapeutics (formerly Cardiovascular Biotherapeutics or CVBT). It is clearly in the 7-figures, but how far into the 7-figures is to be determined. Does anyone know what numbers each of the sides have presented to the judge? (OK, we know Venturis's number - ZERO; that's not going to fly.)
I suspect we will have a ruling in the next 1-2 weeks.
For more information:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155218989
I'm also hearing the rumor that Venturis is exploring another use of their protein drug for COVID-19 patients. I'm hearing that Calvin Wallen III (who has recently appointed himself Chief Science Officer as well as Chairman and CEO) and Grant Gordon have brainstormed together and come up with a brilliant new treatment concept!!! They believe that when Venturis's drug is injected directly into the coronavirus inside patients, the drug causes the virus to have an enormous erection. The immune systems then kicks into gear and attacks the virus aggressively, because it knows that viruses with enormous erections have to go. So Venturis's drug brings the virus to the attention of the immune system, so the immune system can attack and kill it and the patient recovers. I'll bet a Nobel Prize is in Calvin and Grant's futures!
I'm sure LOTS of investors are going to want to invest in Venturis Therapeutics now that that genius Calvin Wallen has made it a coronavirus play for investors--just before Venturis declares bankruptcy.
For more information:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155218989
Your sources are wrong, the judgement is in the many millions. There's no need to discuss the point, we'll have the number very soon. But I understand why you want to publicly deny what we both know to be true, although once the judge gives us the exact number, something tells me you're going to go very quiet. It's game over for Venturis Therapeutics.
For more information:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155218989
Venturis Therapeutics: The End Has Arrived
Goodbye, Venturis Therapeutics (formerly Cardiovascular Biotherapeutics). It's been a not-so-nice ride for this shareholder who has lost 100% of his investment. With Venturis suffering a catastrophic multi-million dollar adverse judgment in favor of Dan Montano (we should be hearing the exact dollar amount soon, but it's clearly in the many millions of dollars), I believe Venturis / CVBT is finished once and for all. I see one of two outcomes:
1) The company pays Dan Montano the full judgment--if it has the cash (and I believe Venturis doesn't - see below).
2) The company doesn't have an ability to pay the judgment and files for bankruptcy once Montano commences his collection efforts which rumors indicate are going to be highly aggressive. If Venturis Therapeutics files for bankruptcy, that may turn out to be an unwise move, because rumors are that Montano has an ability to pierce the corporate veil and is going to equally aggressively pursue the officers and directors personally.
No one should be surprised at this outcome. Venturis Therapeutics may be the new name for Cardiovascular Biotherapeutics (CVBT), but it's still the same old zombie company that has not run a single clinical trial since 2007. I believe there are many reasons why the end is now at hand. But let's be clear, this judgment is simply the straw that broke the camel's back, this ending was inevitable:
1) Insolvent: Venturis Therapeutics is insolvent, except now Venturis Therapeutics was apparently playing Enron-style accounting tricks to make it appear otherwise ("debt-free balance sheet" as some on this message board claim - ummm, right). At the 2018 shareholders meeting (which is just a year and a half ago), Venturis Therapeutics CFO Robert Schleizer stated that the company received a going concern qualification from its auditors. So what had changed since then? Well, I believe we received the answer in message #1434 from someone who reports to have the financials in his/her possession--apparently the financial statements from the auditors were compilations, not audits. A compilation is the auditor's presentation of the company's numbers on its letterhead without an audit or an opinion letter--thus, management's representations of the numbers. And in these compilations, the massive debt seemed to have just magically disappeared--amazing! (No audited financial statements had ever been released by Venturis Therapeutics / Cardiovascular Biotherapeutics (CVBT), which says it all.)
2) Illiquid: Venturis Therapeutics has been unable to pay its debts as they become due, according to bankruptcy judge Gary Spraker in 2019 (when the company was called Cardiovascular Biotherapeutics). This statement of fact was in the public record, no one needed to take my word for it. And while there is a troll(s) who kept saying there's no proof of this, I had previously posted where anyone could find Judge Spraker's conclusion. Go review my previous messages if you would like to see it for yourself, you'll find it in one of them. I promise. :)
3) Alleged crook in charge: The majority shareholder, Chairman, and President of Venturis Therapeutics, Calvin Wallen III, is an accused crook and facing a trial in 2020 (but could be delayed because of the pandemic) brought by the U.S. Government bankruptcy trustee for fraud and allegedly stealing $14 million from his previous company, Tauren Exploration Inc. Mr. Wallen, who only holds a high school diploma but likes to give the impression he has a college degree from Texas A&M that he doesn't have, has successfully delayed his day of reckoning for nearly two years, but it seems unlikely he will make it three. And Mr. Wallen has a trail of bankrupt companies to his name. Does anyone remember Cubic Energy Inc.? (and didn't Cubic Energy also have sketchy accounting behind its demise as well? could there be a pattern here?)
4) Leadership is a revolving door: In the last 18 months the company has lost its President, its Chief Medical Officer, and its Chief Science Officer. And everyone else that remains pretty much appears to be part-timers who also hold other jobs and are not even based in Dallas TX. Can anyone say, window dressing? No one viable stays on a sinking ship.
5) Dead in the water: Not one clinical trial has been run in the last 14 years by Venturis Therapeutics (and counting). The only thing that matters for a development-stage biotech company is running clinical trials, but that's not what Venturis/CVBT seemed to be doing. Instead the company talked like brain-eaten zombies about patents, patents, patents as if that's what really matters. I'd long ago put that zombie patent issue to rest repeatedly, but like a zombie subject, it never died (until it has):
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=153942486
If you'd like to better understand these issues, here is more information:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=153252377
Venturis Therapeutics has already failed and this multi-million dollar judgement is just the final nail in the coffin. There's no mystery left. I predict a Venturis Therapeutics bankruptcy filing soon in order to prevent Dan Montano from collecting. At that point, from the rumors I've heard he will go after the officers and directors personally.
johnnymcgriffin347 there's nothing to fear--with certainty Venturis Therapeutics/CVBT is finished. I believe the company has no money and hasn't had any money since 2007, it's all been smoke and mirrors. With this huge judgement against the company, they'll have two options as best as I call: pay it, or don't pay it and declare bankruptcy (which will result in Dan Montano going after the officers and directors personally for the judgement).
I wouldn't say that Montano clones don't know anything more than many of us. They seem to know that Venturis just suffered a massive binding non-appealable judgement (likely game-ending) at the hands of Dan Montano, and they seem to know that Dan Montano and his lawyers are going to collect every last penny of that judgement, hopefully from Venturis directly, but if not, then from the officers and directors of the company. How could a judgement against a corporation result in personal liability for the officers and directors, you ask? Stay tuned.
By the way, I also received an email from one of Venturis's board members the other day. Let me share it:
I have great faith in Venturis. Before Venturis my life was empty and had no meaning. But I owe everything to Calvin Wallen III. Calvin has saved me. He has given me purpose, showed me what true genius is, and given me reason to live. To my dying day he is the greatest man I have ever known. He is a selfless humanitarian who has given us all so much. Heck, even when I just see his name, a certain feeling comes all over my body. Venturis is simply the greatest company mankind has ever seen. I’ve invested every last penny I have in Venturis and I wish I had more so I could invest even more. Did I tell you I think it is the greatest company ever of all time? I’m thinking of any ways I can get my hands on more money just so I can give it all to Calvin and Venturis. Once Venturis gets its new drug for erectile dysfunction approved by the FDA then maybe I can have an erection again. All the babes will love me and want me because I will be so rich.
And now back to the real world:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=153950894
AWESOME!!! Hopefully Venturis/CVBT can quickly raise many millions of dollars at this high valuation, so the company can then pay off the multi-million dollar judgement it just suffered at the hands of Dan Montano without having to resort to bankruptcy. This is GREAT NEWS.
For more information, here's Accountability 101, coming soon to an insolvent, illiquid, all-but-defunct company near you:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155019287
More hooey from Venturis Therapeutics--impressive! If an annual meeting can't get announced until 60 days before the event, then why did YOU announce it on this message board? It's funny how the rules apply when they suit your purposes--except when they're ignored (and do any such rules apply to privately-held companies as well?--because let's remember, Venturis Therapeutics is a failed de-listed company).
I'm highly, highly confident the day of reckoning for Venturis Therapeutics, its leadership, and its Board of Directors, is imminent. The shareholders all deserve accountability, and I believe that long-overdue accountability is at hand. And I believe there is also going to be accountability for the slander taking place.
Accountability 101:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=153950894
What a load of hooey! Would you please paste a link to where on Venturis Therapeutics's website it says the annual meeting has been re-scheduled to August 2020?
In advance, since we both know no such link exists and you will not be able to point to that information on the company's website, your statement that the annual shareholders meeting has been moved from May to August 2020 is unsubstantiated nonsense. Given the abysmal track record of Venturis/CVBT supporters anonymously and repeatedly posting non-public "information" about the company which has turned out to be false, until we shareholders see this information on the website, your "information" can't be taken even slightly seriously.
Let me again repeat: In my opinion, there will NEVER be another shareholders meeting of Venturis Therapeutics (formerly, Cardiovascular Biotherapeutics or CVBT). The company is insolvent, illiquid, and we will soon hear the details of a massive judgement against the company which will result in its liquidation.
For more information:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=153950894
The non-existent 2020 shareholders meeting for Venturis Therapeutics - formerly Cardiovascular Biotherapeutics (CVBT)
So far we have heard nothing about the 2020 annual shareholders meeting for Venturis Therapeutics (formerly Cardiovascular Biotherapeutics), which is due to be held in May 2020. In past years we would have heard an announcement of the meeting by now, but there's been nothing as of yet, However, I do not believe there will be an annual meeting in 2020, or ever again. I predicted a year ago that the 2019 shareholders meeting would be the last one ever, and so far that prediction appears to be on track. Take a look at that prediction, which was made one year ago when I reported on the contents of the 2019 Venturis / CVBT shareholders meeting:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149029245
With Venturis / CVBT suffering a very recent crushing binding arbitration loss at the hands of Dan Montano (we have yet to learn the amount of damages being awarded, but I have heard rumors that it's MANY millions of dollars--a judgement that in my opinion is the final nail in the coffin for this decrepit company and its grossly incompetent and dishonest leadership), I believe it's OVER for Venturis Therapeutics, forever. Time will tell.
Here is more information:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=153950894
Grant, haven't you tired of keeping up this stupid charade?
It's over.
In the final days of Venturis Therapeutics (formerly Cardiovascular Biotherapeutics or CVBT)...
After suffering what is reportedly a devastating, multi-million dollar judgment that went against Venturis Therapeutics and in favor of Dan Montano, I have heard we are awaiting the judge’s announcement of the final dollar verdict. I’m hearing rumors that it is a substantial seven-figure number, but we’ll just have to wait until we hear from the judge. It shouldn't be long.
I believe we’ve reached the final days of Venturis Therapeutics / CVBT. I predicted less than a year ago that the 2019 annual shareholders meeting would be the final one. That prediction is looking completely correct (Walhall pats self on the back).
Has anyone else heard the rumor that once the final judgment is announced, the judgment creditor is going to aggressively pursue not just Venturis/CVBT but also the officers and directors? Would this mean that a court-ordered creditor’s exam is coming soon to Venturis Therapeutics, which will reveal the truth of Venturis’s finances? Many messages here have indicated that Venturis Therapeutics / CVBT raised $10 million within the last year (so therefore it must be true, right?), so hopefully enough of that money is still left to pay the judgment. If not, I suspect things will get ugly very quickly…
In other matters, I believe we are also very close to getting a new date for the U.S. government bankruptcy trustee’s trial against Calvin Wallen III, Venturis Therapeutics’s controlling shareholder, Chairman, and President. Mr. Wallen is accused by the U.S. government of fraud and allegedly stealing $14 million from his previous company, Tauren Exploration Inc. In spite of Mr. Wallen playing the delay, delay, delay game for nearly 2 years, I believe this next announced date for his trial will hold. I expect to have a full update in 1-2 weeks.
Here are the links to the court records in the cases against Mr. Wallen:
Tauren Exploration, Inc. Liquidating Trust vs. Calvin Wallen III:
https://www.pacermonitor.com/public/case/24021776/Tauren_Exploration,_Inc_Liquidating_Trust_v_Wallen,_III
Tauren Exploration, Inc. Liquidating Trust vs. Pandale Holdings, Inc. et. al:
https://www.pacermonitor.com/public/case/24021775/Tauren_Exploration,_Inc_Liquidating_Trust_v_Pandale_Holdings,_Inc_et_al
Tauren Exploration, Inc. Liquidating Trust v. Fossil Operating, Inc. et al:
https://www.pacermonitor.com/public/case/24021777/Tauren_Exploration,_Inc_Liquidating_Trust_v_Fossil_Operating_Inc_et_al
And here is more information about the dire condition of Venturis Therapeutics:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=153950894
Entering the final days of Venturis Therapeutics / CVBT...
With the multi-million dollar judgement against Venturis Therapeutics (formerly known as Cardiovascular Biotherapeutics or CVBT), I believe Venturis has now reached terminal stage. I can't say exactly when the curtain falls for good, but there is zero doubt in my mind that it's over.
I saw the news release Venturis Therapeutics put up on its website yesterday and could only chuckle at the ineffective effort to sugarcoat/wordsmith a disaster. Venturis Therapeutics seems to want to suggest that this multi-million dollar award to Dan Montano will be inconsequential. Fortunately anyone who has taken Commerical Law 101 in college knows better (or at least those of us who have college diplomas, which excludes Calvin Wallen III and some others in Venturis Therapeutics' leadership).
If Dan Montano has a multi-million dollar judgement against Venturis Therapeutics, he can move to collect against Venturis. If some "affiliate" (which is legally NOT Venturis but let's say an individual officer of Venturis) has a valid enforceable claim against Dan Montano, that does not allow for offset. What that means is that once Dan Montano has collected against Venturis, that individual will have the right to collect against Dan Montano. It does not mean that the individual with the claim can stop Dan Montano from collecting against Venturis, a separate legal entity.
I do not know exactly what comes next. But I am reasonably confident that if Venturis Therapeutics does not pay Dan Montano the millions he is now owed, I suspect Dan Montano will instigate a very aggressive collection effort. Which is why I believe a Venturis Therapeutics bankruptcy filing is imminent, unless Venturis writes Dan Montano a multi-million dollar check, and quickly.
And it will have to come from Venturis's resources or those of Mr. Wallen, because I believe at this point any third parties that were considering investment in Venturis Therapeutics will have walked away (not that I believe there are any such parties). Which is why I believe it's over for Venturis.
Separate from this huge setback for Venturis Therapeutics, let's not forget that its Chairman and President, Calvin Wallen III, is headed to trial sometime later in 2020 for fraud and for allegedly stealing $14 million from his former company that he ran into bankruptcy. Mr. Wallen is being pursued by the U.S. government bankruptcy trustee with its unlimited resources. So far 2020 has not been a good year for Mr. Wallen, and I do not believe it is about to get any better.
Here are the links to the court records in the cases against Mr. Wallen:
Tauren Exploration, Inc. Liquidating Trust vs. Calvin Wallen III:
https://www.pacermonitor.com/public/case/24021776/Tauren_Exploration,_Inc_Liquidating_Trust_v_Wallen,_III
Tauren Exploration, Inc. Liquidating Trust vs. Pandale Holdings, Inc. et. al:
https://www.pacermonitor.com/public/case/24021775/Tauren_Exploration,_Inc_Liquidating_Trust_v_Pandale_Holdings,_Inc_et_al
Tauren Exploration, Inc. Liquidating Trust v. Fossil Operating, Inc. et al:
https://www.pacermonitor.com/public/case/24021777/Tauren_Exploration,_Inc_Liquidating_Trust_v_Fossil_Operating_Inc_et_al
And here is more information about the dire condition of Venturis Therapeutics:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=153950894
The miscalculations by Venturis Therapeutics / CVBT in this matter are going to be a superb business school case study. Filed under, "What happens when unqualified and untrained people play biotechnology."
That said, I agree with you BirnamWood. If I were Calvin Wallen III, Mickael Flaa, Grant Gordon, Robert Schleizer, Jon Ross, or Alfred Moran, I would not be concerned about Dan Montano pursuing me personally for this multi-million dollar judgement. Why? Because we all know that Venturis Therapeutics raised $10 million and has money in the bank (because it has been anonymously revealed on this message board by Venturis/CVBT sources), so the company will just pay Dan Montano as ordered.
And if they don't, well, as sure as my name is Walhall, I have to believe Dan Montano is a forgive-and-forget kind of guy.
Court case ruling - Would you now care to tell us how well you're sleeping SlalomKing?
Is Johnny McGriffen correct that Venturis Therapeutics (CVBT) lost the case? If so, I imagine you are confident they will prevail when they appeal it to the Supreme Court (John Roberts will want to take this on, right?).
Is it true that Venturis Therapeutics owes Dan Montano millions of dollars as Johnny indicated?
Does Venturis Therapeutics have the cash to pay the judgement that Johnny McGriffen reported was levied against the company? If not, is a bankruptcy filing imminent, or will Venturis Therapeutics just let Dan Montano seize its assets?
Do you believe Dan Montano will be aggressive in his collection efforts, or do you believe he will be patient and work with Venturis Therapeutics to get the large sums of money the court reportedly determined he is owed?
It makes no sense that Venturis Therapeutics (formerly Cardiovascular Biotherapeutics or CVBT) would license some other wound healing technology from any university or anyone. We've been consistently told that Venturis Therapeutics's wound healing drug is THE ANSWER to wound healing. So if they are now going in another direction, this says to me they must know that their drug does not work as well as we have all been led to believe. What do they know about it that we don't know? What rational reason exists for them to do this?
And if the issue is lack of funding to run clinical trials as is the case, how does this solve that problem?
This in-licensing move is beyond perplexing...I interpret it as bad news actually. And if Johnny McGriffen is right that CVBT lost the case and Dan Montano won (not that I expect CVBT will do a press release on that, but hopefully we will see the judge's ruling soon), then things are going from bad to worse right now. Not that I perceived it otherwise. Which is why I've been consistently saying that I do not believe Venturis Therapeutics / CVBT will even exist in 2021.
For more information, and to also learn about the U.S. government bankruptcy trustee's case again Venturis Therapeutics's Chairman/President Calvin Wallen III, read this:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=153950894
Any predictions for Venturis Therapeutics bankruptcy filing?
Does anyone have any predictions how soon it will take place?
I believe it's not far away. Here's why:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=153950894
The patent zombies strike again: apples to oranges comparison
Any halfway-informed person reading the back and forth on the patent issue can instantly appreciate that Venturis Therapeutics is presenting appples to oranges, brain-eaten zombie arguments about the immense value of its patents (likely by its leadership writing here anonymously, which is funny because many have reported that company leadership doesn't return actual shareholder phone calls).
The zombie suggestion that the purchase of any development-stage biotech company is linked to the number of patents it has proves only that there really are zombies and they will eat your brain. That's not how it works, and anyone who knows the first thing about biotech doesn't need to be told that. What matters in every one of the examples provided, which is not the case with Venturis Therapeutics, are the following:
1) The acquired development-stage companies have ongoing and advancing clinical trials. Venturis Therapeutics hasn't run a single clinical trial in 14 years and counting. In the eyes of everyone who is not Venturis Therapeutics leadership, this is a broken company and Humpty Dumpty can not be put back together again. Ever.
2) The companies acquired are financially solvent and not bankrupt as Venturis Therapeutics is (in all but name - and don't worry, that formal designation is coming very soon).
3) The companies acquired do not have leadership that is accused by the U.S. government of allegedly stealing $14 million (or any amount) from a previous company which was run into bankruptcy. Here's a truism: No one will as much as touch a company where there is even the whiff of fraud. In Venturis Therapeutics's case, it's not a whiff, it's a stench that is so overpowering you can smell it even over the Internet. Venturis Therapeutics's Chairman/President, Calvin Wallen III, is accused by the U.S. government bankruptcy trustee of fraud and of stealing $14 million from his previous company. As a result, everything about Venturis Therapeutics is radioactive and no one remotely credible will go near it. The end.
Can you say: zzzombie....zzzombie....zzzombie....zzzombie....zzzzzzzz.....
If you'd like to understand these issues in greater detail, here is more information:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=153950894
Venturis Therapeutics: New name, same old zombie company - 3rd update
Venturis Therapeutics may be the new name for Cardiovascular Biotherapeutics (CVBT), but it's still the same old zombie company that has not run a single clinical trial since 2007. I believe there are many reasons why Venturis Therapeutics will be closing its doors for good in 2020.
Here's what I believe is the actual situation at Venturis Therapeutics:
1) Insolvent: Venturis Therapeutics is insolvent, except now Venturis Therapeutics is apparently playing Enron-style accounting tricks to make it appear otherwise ("debt-free balance sheet" as some on this message board claim - ummm, right). At the 2018 shareholders meeting (which is just a year and a half ago), Venturis Therapeutics CFO Robert Schleizer stated that the company received a going concern qualification from its auditors. So what's changed since then? Well, I believe we received the answer in message #1434 from someone who reports to have the financials in his/her possession--apparently the financial statements from the auditors are compilations, not audits. A compilation is the auditor's presentation of the company's numbers on its letterhead without an audit or an opinion letter--thus, management's representations of the numbers. And in these compilations, the massive debt seems to have just magically disappeared--amazing! (No audited financial statements have ever been released by Venturis Therapeutics / Cardiovascular Biotherapeutics (CVBT), which says it all.)
2) Illiquid: Venturis Therapeutics is unable to pay its debts as they become due, according to bankruptcy judge Gary Spraker in 2019 (when the company was called Cardiovascular Biotherapeutics). This is a statement of fact that's in the public record, you don't need to take my word for it. And while there is a troll(s) who keeps saying there's no proof of this, I have previously posted where you can find Judge Spraker's conclusion. Go review my previous messages if you would like to see it for yourself, you'll find it in one of them. I promise. :)
3) Alleged crook in charge: The majority shareholder, Chairman, and President of Venturis Therapeutics, Calvin Wallen III, is an accused crook and facing a trial in 2020 brought by the U.S. Government bankruptcy trustee for fraud and allegedly stealing $14 million from his previous company, Tauren Exploration Inc. Mr. Wallen, who only holds a high school diploma but likes to give the impression he has a college degree from Texas A&M that he doesn't have, has successfully delayed his day of reckoning for nearly two years, but it seems unlikely he will make it three. And Mr. Wallen has a trail of bankrupt companies to his name. Does anyone remember Cubic Energy Inc.? (and didn't Cubic Energy also have sketchy accounting behind its demise as well? could there be a pattern here?)
4) Leadership is a revolving door: In the last year or so the company has lost its President, its Chief Medical Officer, and its Chief Science Officer. And everyone else that remains pretty much appears to be part-timers who also hold other jobs and are not even based in Dallas TX. Can anyone say, window dressing?
5) Dead in the water: Not one clinical trial has been run in the last 14 years: Venturis Therapeutics (and formerly Cardiovascular Biotherapeutics) has not run a single clinical trial in the last 14 years (and counting). The only thing that matters for a development-stage biotech company is running clinical trials, but that's not what Venturis/CVBT seems to be doing. Instead the company talks like brain-eaten zombies about patents, patents, patents as if that's what really matters. I've put that zombie patent issue to rest repeatedly, but like a zombie subject, it never dies:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=153942486
If you'd like to better understand these issues, here is more information:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=153252377
Venturis Therapeutics Zombie Chronicles: Patent Edition
The patent zombies are out in full force continuing to put forward their zombie-eaten, brain-dead arguments about how valuable the patents are at Venturis Therapeutics.
Let's yet again re-state a crucial fact: There is not one Wall Street analyst that values a development-stage biotech company primarily or even secondarily through the prism of patents. NOT ONE.
Do Wall Street analysts value biotech companies that have FDA-approved products on the market and active revenue streams through a prism (but not the only one) of patents? Yes, they do. But a development-stage zombie biotech company that has zero revenues, zero approved drugs, zero ongoing clinical trials, and is insolvent? HELL NO!
That Venturis Therapeutics's supporters feel the need to grossly misrepresent how things work shows one of three things: (1) they're idiots; or (2) they think everyone else is stupid; or (3) zzzombie....zzzombie.....zzzombie....zzzombie.....zzzzzzz.....
But let's not forget that ZOMBIE COMPANIES only talk about things that are irrelevant. What zombie companies don't talk about is the only thing that matters for a development-stage biotech company: running clinical trials. Venturis Therapeutics has not run a single clinical trial in 14 years (and counting). Why don't we talk about this, since it's the only thing that matters?
Here's more information:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=153252377
Seriously, is this how you want to go out? We both know you're promoting a false narrative. If I were staring into the abyss, I'm not sure I'd want to be openly flouting the 10 Commandments. But that's between you and the big guy up there.
It's possible to save face and keep your integrity at the same time.
Involuntary bankruptcy probability has HARDLY gone away at Venturis Therapeutics (formerly Cardiovascular Biotherapeutics or CVBT) in my opinion.
I am so grateful that CVBT’s leadership has spoken to us:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=153870744
Aside from the fact there are more falsehoods put forward than one would even hear from Trump, what’s really helpful is that anyone doing even a little bit of due diligence can quickly and independently determine the lack of veracity for themselves. So thank you for revealing yourselves, Venturis Therapeutics/CVBT leadership.
However, let’s be clear about one thing: The shadow of involuntary bankruptcy for Venturis Therapeutics is hardly receding as some would suggest. Actually I strongly believe it’s intensifying. And the company’s leadership is aware of this as well, notwithstanding the false narrative being put forward (which is one key reason why that narrative exists, in my opinion, to confuse the situation and make it appear more stable than it actually is).
I only share facts that are publicly-verifiable, which is why I am always linking to third party court records and other places where the information I put forward can be confirmed. And my opinions are clearly indicated as such. What I do not do is put forward complete falsehoods.
To learn more, read here:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=153440003
The pathetic failures of Venturis Therapeutics (formerly CVBT)
It says it all that the issues being raised here by people like me who are shareholders of Venturis Therapeutics (formerly Cardiovascular Biotherapeutics or CVBT) focus on facts like these:
1) There have been NO CLINICAL TRIALS IN 14 YEARS (and counting), the leadership of Venturis Therapeutics just gives new timelines and never explains why the old ones were not met, and nothing happens.
2) Venturis Therapeutics is insolvent and according to bankruptcy judge Gary Spraker is unable to pay its bills as they become due.
3) The management team is a revolving door of retired part-timers who don't stick around, except for the Great Leader Calvin Wallen III. He's the guy who controls CVBT, and with his high school diploma (but no other educational degree) leads us all to victory after victory. Or something like that.
4) The latest victories Mr. Wallen has had are delaying his trial brought by the U.S. government bankruptcy trustee, for fraud and allegedly stealing $14 million from his previous company which he led victoriously into bankruptcy. This alleged crook, Mr. Wallen, has successfully delayed his trial for 2 years, but I'm hearing from sources it will definitely happen in 2020. And once he is convicted, it will likely set into motion a cascade of events that I believe will result in Mr. Wallen heading to prison.
The fact that CVBT's leadership refuses to substantively engage these issues EVER says it all. All we get are excuses and lies and talking about Dan Montano (the former CEO who left 6 years ago). But anyway it all won't matter soon, because I believe it's a matter of weeks-to-months before Venturis Therapeutics will be closing its doors for good. I'm looking forward to the accountability that is already taking place.
Here is more information:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=153440003
What about Venturis Therapeutics's NON-EXISTENT clinical trials?
Well, January 2020 has come and gone (and we're now halfway through February as well) and true to form, Venturis Therapeutics (formerly Cardiovascular Biotherapeutics) has not commenced the clinical trial that Calvin Wallen said would be started at the start of 2020. So....would the company's leadership care to anonymously tell us why yet another date has been missed? It's former CEO Dan Montano's fault, right? (who left 6 years ago)
BTW, we are now in the 14th year since Venturis Therapeutics has run a single clinical trial. What a pathetic accomplishment. Is Venturis Therapeutics trying to set a new Guinness World Records thing?
Can you say: zzzombie....zzzombie....zzzombie....zzzombie....zzzombie....zzzombie....zzzzzzz....
Here's more information about this zombie biotech company:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=153440003
It doesn't matter, the final act is here. The curtain is about to come down on Venturis Therapeutics/CVBT soon and all the crooks, both the indicted and to-be-indicted Calvin Wallen III, Grant Gordon, etc. all know it (and so do people like Dr. Meyerson who have escaped from the Titanic). Us shareholders got screwed in 2014 and the screwing has never stopped ever since. What happens next really doesn't matter, because the music is about to end in a matter of weeks-to-months in my opinion.
Here's more information:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=153440003
Venturis Therapeutics - a ZOMBIECORN company
From Investopedia:
A Zombiecorn biotech company is an involvent, de-listed, utterly broken, privately-held company that's all but worthless, but the brains of those close to it have been zombified into believing it's worth $1 billion or more.
Based on extensive research, Investopedia has determined that the consistent traits found in a Zombiecorn biotech company are as follows:
1) The company is insolvent.
2) A bankruptcy court judge has found that the company can not pay its debts as they become due.
3) The company has run no clinical trials in over a decade. That is, zero, zilch, null and void, <ctrl> <alt> <delete>.
4) The company is run by a failed businessman who only has a high school diploma and no college degree, M.D., Ph.D., or MBA.
5) The company spends more money on legal fees than it does on actually running clinical trials (which it spends zero on).
6) Leadership of the company spends their time anonymously posting on the Internet to create an impression of viability, instead of raising money, running clinical trials, or doing the things that actually make a biotech company legitimately viable.
7) The company's Chairman/President is awaiting a trial (which he has successfully delayed for two years) that is being brought by the U.S. government bankruptcy trustee against him for fraud and for allegedly having stolen $14 million from the company he previously ran into bankruptcy.
zzzombie....zzzzzombie...zzzzzzzzzombie.....
Is Venturis Therapeutics a Zombiecorn company? It seems clear that it is, but to be sure, there is another way to determine this:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=153386822
For more information on Venturis Therapeutics (formerly Cardiovascular Biotherapeutics), a Zombiecorn biotech company, take a look at this:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=153440003
The soon-to-be-announced massive Venturis/North Korean deal: SlalomKing must be referring to the massive rumored Venturis Therapeutics (formerly Cardiovascular Biotherapeutics or CVBT) deal with the North Koreans.
There's more information about this "massive deal" here:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150879974
ZOMBIE COMPANY ALERT: Venturis Therapeutics & Patents
Venturis Therapeutics' supporters love to talk about patents, but not about the only thing that matters with a development-stage biotech company: clinical trials. Why not? Because Venturis hasn't run a single clinical trial in 14 years. Do you know what that means? zzzzombie.....zzzzombie.....zzzzzombie...
Further, there is not one Wall Street analyst that values a development-stage biotech company primarily or even secondarily through the prism of patents. Not one.
Do Wall Street analysts value biotech companies that have FDA-approved products on the market and active revenue streams through a prism (but not the only one) of patents? Yes, they do. But a development-stage zombie biotech company that has zero revenues, zero approved drugs, zero ongoing clinical trials, and is insolvent? HELL NO!
That Venturis Therapeutics's supporters feel the need to grossly misrepresent how things work shows one of two things: (1) they're idiots; or (2) they think everyone else is stupid.
But let's not forget that ZOMBIE COMPANIES only talk about things that are irrelevant. What zombie companies don't talk about is the only thing that matters for a development-stage biotech company: running clinical trials.
Here's more information explaining why Venturis Therapeutics is a zombie biotech company:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=153252377
Complete lack of accountability at Venturis Therapeutics (formerly Cardiovascular Biotherapeutics, or CVBT)
Those of us who are shareholders (and not management anonymously posting here) believe in facts, in truth, and in accountability. I believe all of those are absent at Venturis Therapeutics (or Cardiovascular Biotherapeutics as it was until the name changed very recently, in what I believe is an attempt to fool the unsuspecting in the hope they don't find the enormous CVBT baggage).
Everyone knows the saying: A fish rots from its head. Well, everyone also knows that the head of Venturis Therapeutics, Calvin Wallen III, is accused by the U.S. government of fraud and allegedly stealing $14 million from his previous now-bankrupt company. You'll find links below if you'd like to better understand what's going on. How the allegedly-independent Board of Directors allows someone who is accused of such serious transgressions to continue to run the company let alone be on the team, says everything that needs to be said about how derailed this company is.
I've attended every shareholders meeting and took great notes. Mr. Wallen has made promises in these meetings, and none of them have born out. For years we've been hearing dates for re-starting the clinical trials, and the dates ALWAYS come and go and all that happens is the dates are pushed out another year. Rinse and repeat. I'm sick of it! We're now in the 14th year since this company has run a single clinical trial. Leadership refuses to acknowledge any of this and explain what went wrong other than to blame Dan Montano, the former CEO and founder of the company who's been gone for almost 6 years now. Instead they just act as if everything is going according to plan and always has been. In my opinion, these people are either dishonest or grossly inept. I don't know which is worse. Or maybe they're both?
Here is more information about the upcoming trial of Venturis Therapeutics' leader, Calvin Wallen III:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=153583412
And here is more information about why I believe Venturis Therapeutics will be shutting its doors for good in 2020:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=153440003
Complete lack of accountability at Venturis Therapeutics (formerly Cardiovascular Biotherapeutics, or CVBT)
Those of us who are shareholders and not management anonymously posting here believe in facts, in truth, and in acountability. I believe all of those are absent at Venturis Therapeutics (or Cardiovascular Biotherapeutics as it was until the name changed very recently, in what I believe is an attempt to fool the unsuspecting in the hope they don't find the enormous CVBT baggage).
Everyone know the saying: A fish rots from its head. Well, everyone also knows that the head of Venturis Therapeutics, Calvin Wallen III, is accused by the U.S. government of fraud and allegedly stealing $14 million from his previous now-bankrupt company. You'll find links below if you'd like to better understand what's going on. How the allegedly-independent Board of Directors allows someone who is accused of such serious transgressions to continue to run the company let alone be on the team, says everything that needs to be said about how derailed this company is.
I've attended every shareholders meeting and took great notes. Mr. Wallen has made promises in these meetings, and none of them have born out. For years we've been hearing dates for re-starting the clinical trials, and the dates ALWAYS come and go and all that happens is the dates are pushed out another year. Rinse and repeat. I'm sick of it! We're now in the 14th year since this company has run a single clinical trial. Leadership refuses to acknowledge any of this and explain what went wrong other than to blame Dan Montano, the former CEO and founder of the company who's been gone for almost 6 years now. Instead they just act as if everything is going according to plan and always has been. In my opinion, these people are either dishonest or grossly inept. I don't know which is worse. Or maybe they're both?
Here is more information about the upcoming trial of Venturis Therapeutics' leader, Calvin Wallen III:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=153583412
And here is more information about why I believe Venturis Therapeutics will be shutting its doors for good in 2020:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=153440003
ZOMBIE ALERT~~~more zombie company (Venturis Therapeutics) activity reported!
Did anyone else notice that zombie biotech company Venturis Therapeutics (formerly Cardiovascular Biotherapeutics or CVBT) had some activity this week? Yes, a new press release talking about...(drumroll, please)...patents.
Patents, patents, patents. Isn't it all so exciting? By the way, isn't it true that if you amass enough patents, FDA approval becomes automatic? hahahaha
But talking about clinical trials, clinical trials, clinical trials...that's the one thing that zombie companies like Venturis Therapeutics don't do. So Venturis Therapeutics is now in its 14th year since the last clinical trial has run.
But aren't those patents incredible and SO VALUABLE? hahaha
Here is more information on zombie biotech company Venturis Therapeutics, which I believe will close its doors for good in 2020:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=153440003
And let's not forget the upcoming trial for Venturis Therapeutics' Chairman and President, Calvin Wallen III, who is accused by the U.S. government bankruptcy trustee of fraud and allegedly stealing $14 million from his previous company which he ran into bankruptcy:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=153583412
Venturis Therapeutics Chairman/President's Upcoming Fraud Trial - Update
There's some news on the upcoming fraud trial of Calvin Wallen III, the Chairman and President of Venturis Therapeutics. According to court documents, a new date for the trial will be determined in early March 2020 after the latest Calvin Wallen III appeal is exhausted. So by the end of the Q1 2020, we will know when the trial date will likely finally take place.
Mr. Wallen has been accused by the U.S. government bankruptcy trustee for Tauren Exploration of fraud and allegedly stealing $14 million from Tauren while he was CEO of the company. The government has laid out its case showing dates, amounts, and bank accounts that Mr. Wallen allegedly siphoned the stolen monies into. These diversions were uncovered by forensic accountants hired by the bankruptcy trustee to investigate accounting discrepancies.
[Aside: Is it a coincidence that in the last three companies that Mr. Wallen has run (Cubic Energy, Tauren, Cardiovascular Biotherapeutics / Venturis Therapeutics), accounting issues have arisen?]
Mr. Wallen has successfully delayed this case for 2 years, although I believe that his trial will take place once and for all in 2020. So why would Mr. Wallen want to delay his trial given that he is innocent until proven guilty? Well, perhaps it's because under the law, if he is found guilty of a theft of this magnitude and because the U.S. bankruptcy trustee is involved, being found guilty of this $14 million theft will result in automatic referral for criminal prosecution. Additionally, bankruptcy sources I've spoken with have told me that it's all but certain that a guilty verdict will also result in a referral to the IRS to investigate for possible tax evasion. If Mr. Wallen paid taxes on the $14 million he will have been found responsible for having stolen, then he will have no issues with the IRS. But if he did not pay taxes on his illegal income, Mr. Wallen is likely to have something more in common with Al Capone than his momma ever imagined possible.
The good news is that everything I've stated above can be confirmed by reading through the court documents, which can be found here:
Tauren Exploration, Inc. Liquidating Trust vs. Calvin Wallen III:
https://www.pacermonitor.com/public/case/24021776/Tauren_Exploration,_Inc_Liquidating_Trust_v_Wallen,_III
Tauren Exploration, Inc. Liquidating Trust vs. Pandale Holdings, Inc. et. al:
https://www.pacermonitor.com/public/case/24021775/Tauren_Exploration,_Inc_Liquidating_Trust_v_Pandale_Holdings,_Inc_et_al
Tauren Exploration, Inc. Liquidating Trust v. Fossil Operating, Inc. et al:
https://www.pacermonitor.com/public/case/24021777/Tauren_Exploration,_Inc_Liquidating_Trust_v_Fossil_Operating_Inc_et_al
All of the above explains why I believe that Venturis Therapeutics will be shutting down for good in 2020. Here's more information:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=153440003
No, zombie biotech companies like Venturis Therapeutics don't have IPOs (and in my opinion there never will be one for Venturis before it shuts down for good later in 2020 - why do you think they changed the name from Cardiovascular Biotherapeutics? what is it exactly that the company was trying to get away from with the name change?). If an IPO had happened, Investors Hub would have never shut down the illegitimate Venturis Therapeutics message board.
If you're interested in learning more, here's more information:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=153440003
Welcome back, zombie company Venturis Therapeutics board participant(s)! There will be much to discuss about zombie biotech company Venturis Therapeutics here (formerly Cardiovascular Biotherapeutics, which changed its name in what I believe is an unsuccessful effort to escape its zombie past, present, and future up to its liquidation). I for one am planning to continue to disseminate factual information that can be independently confirmed about what's really going on. Plus there will be a blow-by-blow on the company's likely unsuccessful efforts to de-zombify itself before its creditors shut it down for good--which I believe is coming in 2020. So stay tuned, I believe the next few months will be very newsworthy.
To better understand why this zombie biotech company is nearing its end, take a closer look here:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=153440003
Venturis Therapeutics: New name, same old zombie company - 2nd update
Venturis Therapeutics may be the new name for Cardiovascular Biotherapeutics (CVBT), but it's still the same old zombie company that has not run a single clinical trial since 2007 (that's 13 years and counting). I believe there are many reasons why Venturis Therapeutics will be closing its doors for good in 2020.
Here's what I believe is the actual situation at Venturis Therapeutics:
1) Insolvent: Venturis Therapeutics is insolvent, except now Venturis Therapeutics is apparently playing Enron-style accounting tricks to make it appear otherwise ("debt-free balance sheet" as some on this message board claim - ummm, right). At the 2018 shareholders meeting (which is just a year and a half ago), Venturis Therapeutics CFO Robert Schleizer stated that the company received a going concern qualification from its auditors. So what's changed since then? Well, I believe we received the answer in message #1434 from someone who reports to have the financials in his/her possession--apparently the financial statements from the auditors are compilations, not audits. A compilation is the auditor's presentation of the company's numbers on its letterhead without an audit or an opinion letter--thus, management's representations of the numbers. And in these compilations, the massive debt seems to have just magically disappeared--amazing! (No audited financial statements have ever been released by Venturis Therapeutics / Cardiovascular Biotherapeutics (CVBT), which says it all.)
2) Illiquid: Venturis Therapeutics is unable to pay its debts as they become due, according to bankruptcy judge Gary Spraker in 2019 (when the company was called Cardiovascular Biotherapeutics). This is a statement of fact that's in the public record, you don't need to take my word for it. And while there is a troll(s) who keeps saying there's no proof of this, I have previously posted where you can find Judge Spraker's conclusion. Go review my previous messages if you would like to see it for yourself, you'll find it in one of them. I promise. :)
3) Alleged crook in charge: The majority shareholder, Chairman, and President of Venturis Therapeutics, Calvin Wallen III, is an accused crook and facing a trial in 2020 brought by the U.S. Government bankruptcy trustee for fraud and allegedly stealing $14 million from his previous company, Tauren Exploration Inc. Mr. Wallen, who only holds a high school diploma but likes to give the impression he has a college degree from Texas A&M that he doesn't have, has successfully delayed his day of reckoning for nearly two years, but it seems unlikely he will make it three. And Mr. Wallen has a trail of bankrupt companies to his name. Does anyone remember Cubic Energy Inc.? (and didn't Cubic Energy also have sketchy accounting behind its demise as well? could there be a pattern here?)
4) Leadership is a revolving door: In the last year or so the company has lost its President, its Chief Medical Officer, and its Chief Science Officer. And everyone else that remains pretty much appears to be part-timers who also hold other jobs and are not even based in Dallas TX. Can anyone say, window dressing?
If you'd like to better understand these issues, here is more information:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=153252377
And if there's any question in one's mind whether or not Venturis Therapeutics is a zombie company, here's the decisive proof:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=153386822
There's also lots of noise on here about how "valuable" the patents of Venturis Therapeutics / Cardiovascular Biotherapeutics are, which are driving a $1+ billion valuation. That's complete nonsense and 100% at odds with how industry analysts and experts think. Make sure you read this:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=153383543
Important question, Sunny4Daze. In yesterday's email you posted this: Unlike patent information, the financials are not public information. However I can confirm that I have the 2017 & 2018 financials (compiled by Weavers CPA)
Here is my question. Are the financial statements compiled by Weavers as you stated, or audited? If they are audited, do the auditors provide an unqualified opinion letter or a qualified one? If qualified, what are the auditor's qualifications?